Selective suppression of interleukin-12 induction after macrophage receptor ligation

Journal of Experimental Medicine

Volumn 185, Issue 11, 1997, Pages 1977-1985

  Sutterwala, Fayyaz S ^a   Noel, Gary J ^b   Clynes, Raphael ^c   Mosser, David M ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT RECEPTOR; FC RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOMODULATION; MACROPHAGE ACTIVATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

ANIMALS; ANTIBODIES, MONOCLONAL; CALCIUM; DOWN-REGULATION; EGTAZIC ACID; HAEMOPHILUS INFLUENZAE; INTERLEUKIN-10; INTERLEUKIN-12; IONOMYCIN; LIGANDS; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; RECEPTORS, COMPLEMENT; RECEPTORS, IGG; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030926583     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.11.1977     Document Type: Article

References (41)

1. Trinchieri, G., and F. Gerosa. 1996. Immunoregulation by interleukin-12. J. Leukocyte Biol. 59:505-511.
2. + T cells through IL-12 produced by Listeria-induced macrophages. Science (Wash. DC). 260:547-549.
3. Manetti, R., P. Parronchi, M.G. Giudizi, M.-P. Piccini, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (NKSF/IL-12) induces Th1-type specific immune responses and inhibits the development of IL-4 producing Th cells. J. Exp. Med. 177:1199-1204.
4. Magram, J., S.E. Connaughton, R.R. Warrier, D.M. Carvajal, C.Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D.A. Faherty, and M.K. Gately. 1996. IL-12-deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity. 4:471-481.
5. Kobayashi, M., L. Fitz, M. Ryan, R.M. Hewick, S.C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J. Exp. Med. 170:827-839.
6. Wolf, S.F., P.A. Temple, M. Kobayashi, D. Young, M. Dicig L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R.M. Hewick, et al. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146:3074-3081.
7. + T cells to enhance priming for interferon-gamma production and diminishes interleukin-4 inhibition of such priming. Proc. Natl. Acad. Sci. USA. 90:10188-10194.
8. Heinzel, F.P., D.S. Schoenhaut, R.M. Rerko, L.E. Rosser, and M.K. Gately. 1993. Recombinant interleukin-12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505-1512.
9. Sypek, J.P., C.L. Chung, S.E.H. Mayor, J.M. Subramanyam, S.J. Goldman, D.S. Sieburth, S.F. Wolf, and R.G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797-1802.
10. Tripp, C.S., W.F. Wolf, and E.R. Unanue. 1993. Interleukin-12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis and interleukin-10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA. 90:3725-3729.
11. Gazzinelli, R.T., M. Wysocka, S. Hayasi, E.Y. Denkers, S. Hieny, P. Caspar, G. Trinchieri, and A. Sher. 1994. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:2533-2543.
12. Cooper, A.M., A.D. Roberts, E.R. Rhoades, J.E. Callahan, D.M. Getzy, and I.M. Orme. 1995. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology. 84:423-432.
13. Mattner F., J. Magram, J. Ferrante, P. Launois, K. Dipadova, R. Behin, M.K. Gately, J.A. Louis, and G. Alber. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26:1553-1559.
14. Scharton-Kerston T., L.C.C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995. Interleukin-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154: 5320-5330.
15. Tripp, C.S., M.K. Gately, J. Hakimi, P. Ling, and E.R. Unanue. 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by interferon-γ. J. Immunol. 152:1883-1887.
16. Afonso, L.C., T.M. Scharton, L.Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science (Wash. DC). 263:235-237.
17. Miller, M.A., M.J. Skeen, and H.K. Ziegler. 1995. Nonviable bacterial antigens administered with interleukin-12 generates antigen-specific T cell responses and protective immunity against Listeria monocytogenes. J. Immunol. 155:4817-4828.
18. Trembleau, S., G. Penna, E. Bosi, A. Mortara, M.K. Gately, and L. Adorini. 1995. Interleukin-12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:817-821.
19. Leonard, J.P., K.E. Waldburger, and S.J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin-12. J. Exp. Med. 181:381-386.
20. Germann, T., J. Szeliga, H. Hess, S. Storkel, F.J. Podlaski, M.K. Gately, E. Schmitt, and E. Rude. 1995. Administration of interleukin 12 in combination with type II collagen induces severe arthiritis in DBA/1 mice. Proc. Natl. Acad. Sci. USA. 92:4823-4827.
21. Gubler, U., A.O. Chua, D.S. Schoenhaut, C.M. Dwyer, W. McComas, R. Motyka, N. Nabavi, A.G. Wolitzky, P.M. Quinn, P.C. Familletti, and M.K. Gately. 1991. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA. 88:4143-4147.
22. Cleveland, M.G., J.D. Gorham, T.L. Murphy, E. Tuomanen, and K.M. Murphy. 1996. Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect. Immun. 64:1906-1912.
23. D'Andrea, A., M. Rengaraju, N.M. Valiante, J. Chehimi, M. Kubin, M. Aste, S.H. Chan, M. Kobayashi, D. Young, E. Nickbarg, R. Chizzonite, S.F. Wolf, and G. Trinchieri. 1992. Production of natural killer cell stimulatory factor (NKSF/IL-12) by peripheral blood mononuclear cells. J. Exp. Med. 176: 1387-1398.
24. Cassatella, M.A., L. Meda, S. Gaspenni, A. D'Andrea, X. Ma, and G. Trinchieri. 1995. Interleukin-12 production by human polymorphonuclear leukocytes. Eur. J. Immunol. 25:1-5.
25. Hayes, M.P., J. Wang, and M.A. Norcross. 1995. Regulation of interleukin-12 expression in human monocytes: selective priming by IFN-γ of LPS inducible p35 and p40 genes. Blood. 86:646-650.
26. Ma, X., J.M. Chow, G. Gri, G. Carra, F. Gerosa, S.F. Wolf, R. Dzialo, and G. Trinchieri. 1996. The interleukin-12 p40 gene promoter is primed by interferon-γ in monocytic cells. J. Exp. Med. 183:147-157.
27. D'Andrea, A., M. Aste-Amezaga, N.M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin-10 inhibits human lymphocyte IFN-γ production by suppressing natural killer cell stimulatory factor/interleukin-12 synthesis in accessory cells. J. Exp. Med. 178:1041-1048.
28. D'Andrea, A., X. Ma, M. Aste-Amezaga, C. Paganin, and G. Trinchieri. 1995. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor-α production. J. Exp. Med. 181: 537-546.
29. Carrera, L., R.T. Gazzinelli, R. Badolato, S. Hieny, W. Muller, R. Kuhn, and D.L. Sacks. 1996. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 183:515-526.
30. Karp, C.L., M. Wysocka, L.M. Wahl, J.M. Ahearn, P.J. Cuomo, B. Sherry, G. Trinchieri, and D.E. Griffin. 1996. Mechanism of suppression of cell-mediated immunity by measles virus. Science (Wash. DC). 273:228-231.
31. Chougnet, C., T.A. Wynn, M. Clerici, A.L. Landay, H.A. Kessler, J. Rusnak, G.P. Melcher, A. Sher, and G.M. Shearer. 1996. Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J. Inf. Dis. 174:46-53.
32. Chehimi, J., S.E. Starr, I. Frank, A. D'Andrea, X. Ma, R. MacGregor, J. Sennelier and G. Trinchieri. 1994. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179:1361-1366.
33. Takai, T., M. Li, D. Sylvestre, R. Clynes, and J.V. Ravetch. 1994. FcR γ chain deletion results in pleiotrophic effector cell defects. Cell. 76:519-529.
34. Johnson, C.R., D. Kitz, and J.R. Little. 1983. A method for the derivation and continuous propagation of cloned murine bone marrow macrophages. J. Immunol. Methods. 65:319-332.
35. Butler, P.J.G., and B.S. Hartley. 1972. Maleylation of amino groups. Methods Enzymol. 25:191-199.
36. Sutterwala, F.S., L.A. Rosenthal, and D.M. Mosser. 1996. Cooperation between CR1 (CD35) and CR3 (CD11b/CD18) in the binding of complement-opsonized particles. J. Leukocyte Biol. 59:883-890.
37. Noel, G.J., S.K. Hoiseth, and P.J. Edelson. 1992. Type b capsule inhibits ingestion of Haemophilus influenzae by murine macrophages: studies with isogenic encapsulated and unencapsulated strains. J. Inf. Dis. 166:178-182.
38. Reiner, S.L., S. Zheng, D.B. Corry, and R.M. Locksley. 1993. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods. 165:37-46.
39. Wysocka, M., M. Marek, L.Q. Vieira, L. Ozmen, G. Garotta, P. Scott, and G. Trinchieri. 1995. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25: 672-676.
40. Kincycain, T., J.D. Clements, and K.L. Bost. 1996. Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infect. Immun. 64:1437-1440.
41. Skeen, M.J., M.A. Miller, T.M. Shinnick, and H.K. Ziegler. 1996. Regulation of murine macrophage IL-12 production: activation of macrophages in vivo, restimulation in vitro and modulation by other cytokines. J. Immunol. 156:1196-1206.